These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 31911449)

  • 21. Homozygous familial hypercholesterolaemia: development of xanthogranuloma in a boy at puberty under long-term low-density lipoprotein apheresis and drug therapy.
    Saito M; Tada Y; Harada-Shiba M; Yamamoto A; Kusakabe N; Yokogawa M; Kodama H; Asada H; Miyagawa S
    Br J Dermatol; 2003 Dec; 149(6):1302-3. PubMed ID: 14674920
    [No Abstract]   [Full Text] [Related]  

  • 22. Statins and other lipid-lowering therapy and pregnancy outcomes in homozygous familial hypercholesterolaemia: A retrospective review of 39 pregnancies.
    Botha TC; Pilcher GJ; Wolmarans K; Blom DJ; Raal FJ
    Atherosclerosis; 2018 Oct; 277():502-507. PubMed ID: 30270091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microsomal triglyceride transfer protein inhibitor (lomitapide) efficacy in the treatment of patients with homozygous familial hypercholesterolaemia.
    Kolovou G; Diakoumakou O; Kolovou V; Fountas E; Stratakis S; Zacharis E; Liberopoulos EN; Matsouka F; Tsoutsinos A; Mastorakou I; Katsikas T; Mavrogeni S; Hatzigeorgiou G
    Eur J Prev Cardiol; 2020 Jan; 27(2):157-165. PubMed ID: 31403880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Management in familial hypercholesterolaemia in children and adolescents. Position of the Lipid Expert Forum].
    Myśliwiec M; Walczak M; Małecka-Tendera E; Dobrzańska A; Cybulska B; Filipiak KJ; Mazur A; Jarosz-Chobot P; Szadkowska A; Rynkiewicz A; Chybicka A; Socha P; Brandt A; Kubalska J; Bautembach-Minkowska J; Limon J; Zdrojewski T; Limon J; Banach M;
    Kardiol Pol; 2013; 71(10):1099-105. PubMed ID: 24197602
    [No Abstract]   [Full Text] [Related]  

  • 25. Images in clinical medicine. Homozygous familial hypercholesterolemia.
    Genest J; Lavoie MA
    N Engl J Med; 1999 Aug; 341(7):490. PubMed ID: 10441605
    [No Abstract]   [Full Text] [Related]  

  • 26. [Familial hypercholesterolemia: recognition and prevention of cardiac complications at a young age].
    Trip MD; Lansberg PJ; de Jongh S; Kastelein JJ
    Ned Tijdschr Geneeskd; 2000 Jul; 144(30):1425-8. PubMed ID: 10932693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver transplantation for the treatment of homozygous familial hypercholesterolaemia in an era of emerging lipid-lowering therapies.
    Page MM; Ekinci EI; Jones RM; Angus PW; Gow PJ; O'Brien RC
    Intern Med J; 2014 Jun; 44(6):601-4. PubMed ID: 24946816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intertriginous xanthomas: a marker of homozygous type IIa hyperlipoproteinemia.
    Manchanda Y; Sharma VK
    Int J Dermatol; 2004 Sep; 43(9):676-7. PubMed ID: 15357750
    [No Abstract]   [Full Text] [Related]  

  • 29. Null receptor homozygous familial hypercholesterolaemia:
    Sampietro T; Sbrana F; Bigazzi F; Ripoli A; Dal Pino B
    Eur J Prev Cardiol; 2020 Dec; 27(19):2105-2108. PubMed ID: 31299859
    [No Abstract]   [Full Text] [Related]  

  • 30. Extracorporeal treatment of hypercholesterolaemia.
    Olbricht CJ
    Nephrol Dial Transplant; 1993; 8(9):814-20. PubMed ID: 8255513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homozygous familial hypercholesterolaemia.
    Macchiaiolo M; Gagliardi MG; Toscano A; Guccione P; Bartuli A
    Lancet; 2012 Apr; 379(9823):1330. PubMed ID: 22285056
    [No Abstract]   [Full Text] [Related]  

  • 32. Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia.
    Marais AD; Naoumova RP; Firth JC; Penny C; Neuwirth CK; Thompson GR
    J Lipid Res; 1997 Oct; 38(10):2071-8. PubMed ID: 9374129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated lipid clinics for adults and children with familial hypercholesterolaemia.
    Garrett EL; Chodhari R
    BMJ; 2018 Jan; 360():k75. PubMed ID: 29335316
    [No Abstract]   [Full Text] [Related]  

  • 34. Homozygous familial hypercholesterolaemia: New hope for getting patients to goal?
    Stock JK
    Atherosclerosis; 2020 Jul; 304():55-56. PubMed ID: 32534726
    [No Abstract]   [Full Text] [Related]  

  • 35. Homozygous familial hypercholesterolaemia: update on management.
    France M
    Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal management of familial hypercholesterolemia: treatment and management strategies.
    Nemati MH; Astaneh B
    Vasc Health Risk Manag; 2010 Dec; 6():1079-88. PubMed ID: 21191428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regression of atherosclerosis in patients with familial hypercholesterolaemia under LDL-apheresis.
    Borberg H; Gaczkowski A; Hombach V; Oette K; Stoffel W
    Prog Clin Biol Res; 1988; 255():317-26. PubMed ID: 3340643
    [No Abstract]   [Full Text] [Related]  

  • 38. The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia.
    Drouin-Chartier JP; Tremblay AJ; Bergeron J; Lamarche B; Couture P
    Circulation; 2017 Aug; 136(9):880-882. PubMed ID: 28847800
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypercholesterolaemia: management and nursing implications.
    Babb Y; Eyre C
    Paediatr Nurs; 2005 Mar; 17(2):35-8. PubMed ID: 15793988
    [No Abstract]   [Full Text] [Related]  

  • 40. Familial Hypercholesterolaemia Regression Study and its implications.
    Watts GF
    Lancet; 1995 Apr; 345(8953):807-8. PubMed ID: 7898224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.